Objective: A meta-analysis to determine the association between chronic pancreatitis and glutathione-S transferase (GST) mu 1 (GSTM1) and theta 1 (GSTT1) deletions. Methods: Case-control studies concerning the relationship between chronic pancreatitis and GSTM1 or GSTT1 deletions were identified (up to October 2013). Meta-analyses of the association between GSTM1 and GSTT1 genotype and chronic pancreatitis or alcoholic chronic pancreatitis (ACP) were performed. Results: Seven studies were included in the meta-analysis (650 patients/1382 controls for GSTM1 and 536 patients/1304 controls for GSTT1). There were no significant relationships between GSTM1/GSTT1 and chronic pancreatitis or GSTT1 and ACP. There was a significant association between GSTM1 null genotype and ACP (odds ratio 1.16, 95% confidence intervals 1.03, 1.30). Conclusion: The GSTM1 null genotype was significantly associated with ACP risk.
Oxidative stress has been implicated in the pathogenesis of chronic pancreatitis, 9 and upregulation of endogenous free-radical scavengers can limit oxidative stress. These include glutathione-S transferases (GSTs): a superfamily of phase II cytosolic, mitochondrial and microsomal enzymes. GSTs mediate the conjugation of reduced glutathione to electrophilic species on a variety of substrates, resulting in the elimination of toxic substances and protecting cells against electrophiles and products of oxidative stress. [10] [11] [12] Null genotypes of both the GST mu 1 (GSTM1) and GST theta 1 (GSTT1) genes exist, where a 15 or 50 kb sequence deletion occurs, leading to a lack of active isoforms when homozygous. The frequencies of GSTM1-null and GSTT1-null vary between 20 and 70%, and 11 and 38%, respectively. [11] [12] [13] The association between chronic pancreatitis and GSTM1/GSTT1 deletion has been studied in various populations, but the results remain inconclusive. The aim of the present meta-analysis was to perform a systematic review of studies evaluating GSTM1 and GSTT1 genotypes and the risk of chronic pancreatitis.
Materials and methods
Studies examining the association between GSTM1/GSTT1 genotypes and susceptibility to chronic pancreatitis were identified by searching PubMed, Science Citation Index and Chinese National Knowledge Infrastructure (CNKI) databases, without a language limitation. Studies published between January 1966 and October 2013 were identified using the keywords ''GSTM1'' or ''GSTT1'' in combination with ''pancreatitis''. Inclusion criteria were: (i) studies concerning the relationship between chronic pancreatitis and GSTM1 or GSTT1 genotype; (ii) case-control studies; (iii) data must include sample size, odds ratios (OR) and 95% confidence intervals (CI), as well as genetic distribution or other information that could help infer these data.
When studies included several separate chronic pancreatitis types (including alcoholic chronic pancreatitis [ACP], hereditary chronic pancreatitis [HCP], nonhereditary chronic pancreatitis [NHCP] and idiopathic chronic pancreatitis [ICP]), pooled data were used to identify the association between GSTM1 and GSTT1 genotypes with CP. When studies included several separate control groups (including inpatients without pancreatic disease, healthy controls, healthy alcoholics, nonalcoholic healthy volunteers and blood donors), data from these control groups were pooled for analysis.
Meta-analysis
Newcastle-Ottawa Scale (NOS) criteria were used to assess study quality. Those studies that met five or more NOS criteria were considered high quality. 14 Meta-analysis was performed using Stata Õ version 12.0 (StataCorp, College Station, TX, USA). For GSTM1 and GSTT1, unadjusted OR and 95% CI from each study were used to estimate summary OR. I 2 -value and 2 -based Q-test were performed to assess heterogeneity. OR were pooled according to the Mantel-Haenszel fixed-effect model, and the significance of pooled OR was determined using Z-test. Publication bias was assessed via funnel plot and Egger's test. Sensitivity analysis was conducted by removing one study at a time, to evaluate the quality and consistency of the metaanalysis findings. P-values <0.05 were considered statistically significant.
Results
The literature search identified 16 relevant publications. Of these, one review article, 15 seven articles regarding other diseases [16] [17] [18] [19] [20] [21] [22] and one study regarding a different gene were excluded. 23 The remaining seven studies satisfied all inclusion criteria and were included in the meta-analysis (GSTM1, 650 cases/1382 controls; GSTT1, 536 cases/1304 controls) ( Table 1) . [24] [25] [26] [27] [28] [29] [30] All publications were written in English and evaluated the GSTM1 genotype; six also evaluated GSTT1. [25] [26] [27] [28] [29] [30] All studies were considered high quality, according to NOS criteria.
Results of the meta-analysis for GSTM1 and risk of chronic pancreatitis (650 cases/ 1382 controls) are shown in Figure 1 . There was significant heterogeneity (P ¼ 0.042), no significant association between GSTM1 and chronic pancreatitis, and no significant publication bias.
Findings of the meta-analysis for GSTT1 and chronic pancreatitis (536 cases/1304 controls) are shown in Figure 2 . There was no significant heterogeneity, no significant association between chronic pancreatitis and GSTT1 and no significant publication bias.
Findings of the meta-analysis for the association between ACP and GSTM1 (597 cases/1286 controls) are shown in Figure 3 . There was no significant heterogeneity or publication bias. There was a significant association between ACP and GSTM1 (OR 1.16, 95% 1.03, 1.30).
The meta-analysis for GSTT1 and ACP (483 cases/1208 controls; Figure 4 ) found no significant heterogeneity, no significant association between ACP and GSTT1, and no significant publication bias.
Sensitivity analyses found that no individual study significantly altered the pooled results for any meta-analysis (data not shown).
Discussion
This meta-analysis is, to the best of our knowledge, the first systematic review of the association between chronic pancreatitis and GSTM1/GSTT1 genotype. Our findings indicate that GSTM1 is associated with ACP. Analysis of the association between GSTM1/GSTT1 and ACP indicated that GSTM1 null genotypes significantly decreased the risk of ACP.
This meta-analysis was based on a limited number of publications that studied several forms of chronic pancreatitis including ACP, HCP, NHCP and ICP. These types of chronic pancreatitis have different pathogeneses. For example, ACP is caused by alcohol consumption, and HCP is a rare chronic pancreatitis resulting from genetic factors. 31 The inclusion of various forms of disease may be responsible for the lack of association between GSTM1/GSTT1 and the risk of chronic pancreatitis, but further studies are required to elucidate this.
Alcohol abuse is a serious medical and socio-economic problem. 32 Consumption of large quantities of alcohol can cause severe oxidative stress in pancreatic cells, and lead to the production of superoxides and cytotoxic substances that cause DNA damage and cellular denaturation. Oxidative stress due to heavy drinking can cause chronic pancreatitis, with detoxification enzymes playing important roles in this process. 33 Polymorphisms in detoxification enzymes differ according to ethnicity. 34 GSTM1 and GSTT1 polymorphisms are associated with diseases including lung cancer, [35] [36] [37] type 2 diabetes mellitus 38 and acute leukaemia. 39 The present metaanalysis found a significant association between GSTM1 null genotypes and the risk of ACP. In contrast to our findings, another meta-analysis found that the GSTM1 null genotype was associated with a higher risk of oral cancer in Asians but not in Caucasians, and the GSTT1 null genotype was not related to oral cancer. 40 This apparent contradiction has several possible explanations: (i) our meta-analysis included a small number of studies; (ii) we observed significant heterogeneity; (iii) there was wide control-group variation in the included studies. The present study found significant heterogeneity in the meta-analysis of the association between GSTM1 and chronic pancreatitis. Frequencies of GSTM1 and GSTT1 null genotypes differ widely according to ethnicity. GSTM1 null genotype frequencies are 42-60%, 42-54%, 16-36%, 54.6% and 55.5% in Caucasians, Asians, Africans, Middle East-Arabs and Egyptians, respectively; GSTT1 null genotype frequencies are 13-16%, 35-52%, 15-26%, 25% and 29.5% in these groups, respectively. 41 Subgroup analyses according to ethnicity as well as meta-regression analyses are required to investigate the possible reasons for heterogeneity, but the present study did not include sufficient data to permit such an analysis.
Our meta-analysis has several limitations. First, although no evidence of publication bias was observed, our results were based on relatively few studies with small sample sizes, therefore publication bias cannot be definitively ruled out. Secondly, significant heterogeneity was observed in our analysis, and underlying heterogeneity may be due to subject age and sex, and variations in sample sizes, study design and genotyping methods. Thirdly, crude OR from each study were used to estimate summary OR and it is 24-27,29.30 possible that some uncontrolled confounding was present. Finally, the majority of included studies did not test for Hardy-Weinberg equilibrium. Large, well-designed studies are required, in order to provide more accurate data.
In conclusion, the present meta-analysis revealed a significant association between the GSTM1 null genotype and the risk of ACP.
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